Cutting down the penalty recommended by its Adjudicative Officer by Rs 70 lakh, Insurance Regulatory and Development Authority of India (IRDAI) has penalised SBI General Insurance Company Ltd Rs 30 lakh for repeatedly violating Insurance Act and the regulations....
German biotechnology company BioNTech on Monday announced plans to expand its global footprint to Asia by building its first mRNA manufacturing facility in Singapore. ...
To offer a safer shopping experience amid the second wave of the pandemic, global premium smartphone brand TECNO on Monday brought back its unique "Doorstep Delivery" initiative with its largest retail network of more than 50,000 outlets in India....
The Covid-19 pandemic has brought automation technologies to the forefront and the Intelligent Automation (IA) market in India is estimated to grow at a compound annual growth rate (CAGR) of 55 per cent, with large enterprises expected to spend nearly $340-$350 million in IA capabilities in 2024, a new report said on Monday....
VS Motors and Sundaram Clayton Ltd on Monday donated 500 oxygen concentrators to the Tamil Nadu government through their social arm, the Srinivasan Services Trust....
India's vehicle registrations declined by 31.83 per cent in April 2021 on a year-on-year (YoY) basis....
India's organised food services market may grow at about 10.5 per cent CAGR to $37 billion over during FY20-25, said a report by Kotak Institutional Equities. ...
Apple on Monday announced to award $45 million from its Advanced Manufacturing Fund to smartphone glass manufacturer Corning Incorporated to expand manufacturing capacity in the US and drive research and development into new technologies....
In a big relief to individuals operating as partners in partnership firms, the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal (CESTAT) has held that any remuneration received by them, as per the obligation of the partnership deed, would be treated as share of profit and not as service under service tax l...
Eli Lilly announced that it has issued royalty-free, non-exclusive voluntary licenses to Indian pharmaceutical manufacturers of generic medicines, Cipla Ltd., Lupin Ltd. and Sun Pharmaceutical Industries Ltd., who are collaborating with Lilly to accelerate and expand the availability of baricitinib in India. ...
